Pharmaxis raises new funds for lead therapeutic
05 June 2009
Ian Haydock
Please Login to read the full article.
05 June 2009
Ian Haydock
ian.haydock@informa.com
Pharmaxis has raised A$47 million ($37.6 million) in new funding which it will use mainly to support the commercialisation of its lead therapeutic product in the US and Europe.
The Australian company issued 20 million new ordinary shares to Australian and international investors at A$2.35...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Pharmaxis seeks re-examination of negative CHMP opinion for cystic fibrosis drug
- Pharmaxis battered by negative CHMP trend vote for cystic fibrosis drug
- First time unlucky for Australian listing of Pharmaxis' cystic fibrosis drug
- Alchemia locks in new funding as it preps for oncology spin-off
FEATURES
Other Informa Features
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
